Clinical Research Directory
Browse clinical research sites, groups, and studies.
Analysis of Various Treatment Methods of Granulomatous Lobular Mastitis
Sponsor: First Affiliated Hospital of Harbin Medical University
Summary
Granulomatous lobular mastitis (GLM) is a rare benign breast disease that is difficult to distinguish from breast cancer based on clinical and imaging findings, and there is currently no standard treatment. This study aims to analyze the clinical characteristics and demographic data of GLM patients and to compare the overall effectiveness of three treatment methods: surgery alone, triple anti-tuberculosis drug therapy alone, and combined surgery with triple anti-tuberculosis drug therapy, with the goal of providing new insights for clinical treatment.
Official title: Analysis of the Clinical Characteristics and Three Treatment Methods of Granulomatous Lobular Mastitis
Key Details
Gender
FEMALE
Age Range
15 Years - 65 Years
Study Type
OBSERVATIONAL
Enrollment
350
Start Date
2024-08-19
Completion Date
2024-10-19
Last Updated
2024-08-22
Healthy Volunteers
Not specified
Conditions
Interventions
Surgery
patients underwent complete excision of the inflammatory breast tissue and some surrounding normal tissue under combined intravenous with inhalation anesthesia. Damaged skin was also removed.
triple anti-tuberculosis drug
Patients took oral rifampin (450 mg/day), isoniazid (300 mg/day), and ethambutol (15 mg/kg/day).
Locations (1)
First affiliated hospital of Harbin medical university
Harbin, Heilongjiang, China